In this op-ed, Melissa Herd, Region 3 Director of the U.S. Department of Health and Human Services, explains how the Biden-Harris Administration's Inflation Reduction Act allows Medicare to negotiate lower prices for 10 prescription drugs, potentially saving billions for taxpayers and Medicare enrollees, with the new prices taking effect on January 1, 2026.